China National Accord Medicines Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000009N6
CNY
25.15
-0.05 (-0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
18,454.41
18,248.81
17,864.44
18,634.44
18,644.98
19,045.00
18,842.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
18,454.41
18,248.81
17,864.44
18,634.44
18,644.98
19,045.00
18,842.59
Raw Material Cost
16,824.20
16,761.61
16,225.06
17,105.37
17,033.93
17,424.99
16,777.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
47.47
43.63
59.75
67.47
76.34
54.75
64.87
Selling and Distribution Expenses
1,176.61
1,095.31
1,351.32
1,160.37
1,216.55
1,147.47
1,370.20
Other Expenses
-4.22
-3.82
-5.49
-6.17
-7.01
-4.90
-5.64
Total Expenditure (Excl Depreciation)
18,006.04
17,862.37
17,581.22
18,271.55
18,256.73
18,578.26
18,156.11
Operating Profit (PBDIT) excl Other Income
448.40000000000003
386.4
283.2
362.9
388.29999999999995
466.70000000000005
686.5
Other Income
2.03
-2.91
-56.15
20.92
-16.35
29.73
-10.31
Operating Profit (PBDIT)
866.97
801.21
-317.86
821.62
797.03
927.71
1,077.78
Interest
47.47
43.63
59.75
67.47
76.34
54.75
64.87
Exceptional Items
0.00
0.00
-23.82
0.00
3.15
0.00
-32.59
Gross Profit (PBDT)
1,630.22
1,487.20
1,639.38
1,529.08
1,611.05
1,620.01
2,065.15
Depreciation
419.47
419.47
438.83
438.83
433.05
433.05
410.55
Profit Before Tax
400.03
338.11
-840.26
315.32
290.79
439.91
569.78
Tax
114.87
90.65
77.67
72.88
83.79
104.13
144.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
337.91
328.00
-423.05
322.05
354.72
388.77
409.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
337.91
328.00
-423.05
322.05
354.72
388.77
409.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
27.01
19.68
-435.62
3.56
-30.78
57.35
98.70
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
364.92
347.68
-858.67
325.61
323.93
446.12
508.29
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
18,136.17
17,997.53
17,669.53
18,101.88
17,779.82
17,803.58
17,414.81
Earnings per share (EPS)
0.61
0.59
-0.76
0.58
0.64
0.7
0.74
Diluted Earnings per share
0.61
0.59
-0.76
0.58
0.64
0.7
0.74
Operating Profit Margin (Excl OI)
2.41%
2.11%
-3.92%
1.94%
2.04%
2.44%
3.6%
Gross Profit Margin
4.44%
4.15%
-2.25%
4.05%
3.88%
4.58%
5.2%
PAT Margin
1.83%
1.8%
-2.37%
1.73%
1.9%
2.04%
2.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.13% vs 2.15% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 4.95% vs 140.49% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 7.56% vs 407.26% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 8.94% vs -26.97% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of China National Accord Medicines Corp. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
18,454.41
0
18,454.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
18,454.41
0
18,454.41
Raw Material Cost
16,824.20
0
16,824.20
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
47.47
0
47.47
Selling and Distribution Expenses
1,176.61
0
1,176.61
Other Expenses
-4.22
0.00
-4.22
Total Expenditure (Excl Depreciation)
18,006.04
0
18,006.04
Operating Profit (PBDIT) excl Other Income
448.37
0.00
448.37
Other Income
2.03
0
2.03
Operating Profit (PBDIT)
866.97
0
866.97
Interest
47.47
0
47.47
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,630.22
0
1,630.22
Depreciation
419.47
0
419.47
Profit Before Tax
400.03
0
400.03
Tax
114.87
0
114.87
Provisions and contingencies
0
0
0.00
Profit After Tax
337.91
0
337.91
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
337.91
0
337.91
Share in Profit of Associates
0
0
0.00
Minority Interest
27.01
0
27.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
364.92
0
364.92
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
18,136.17
0
18,136.17
Earnings per share (EPS)
0.61
0
0.61
Diluted Earnings per share
0.61
0
0.61
Operating Profit Margin (Excl OI)
2.41%
0%
0.00
2.41%
Gross Profit Margin
4.44%
0%
0.00
4.44%
PAT Margin
1.83%
0%
0.00
1.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,845.44 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 1.13% vs 2.15% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -1.02% vs -5.13% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 36.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.95% vs 140.49% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.66% vs -43.04% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 86.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 7.56% vs 407.26% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 6.33% vs -20.40% in Jun 2024

Quarterly - Interest
Interest 4.75 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 8.94% vs -26.97% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -37.75% vs 54.77% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.41%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024